Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Alpha-Tectorin, Interleukin-10, and Thiol-Disulfide Homeostasis in Individuals With Congenital Hearing Loss

NCT07860580 is registered in ClinicalTrials.gov with Harran University as lead sponsor.

NCT NCT07860580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07860580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Alpha-Tectorin, Interleukin-10, and Thiol-Disulfide Homeostasis in Individuals With Congenital Hearing Loss
Lead sponsor
Harran University
Phase
Observational
Overall status
Recruiting
Start date
April 20, 2026
Completion date
April 30, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital hearing loss, sensorineural hearing loss